150 related articles for article (PubMed ID: 8941027)
21. Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
[TBL] [Abstract][Full Text] [Related]
22. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
[TBL] [Abstract][Full Text] [Related]
24. Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose.
Heath A; Svensson C; Mårtensson E
Vet Hum Toxicol; 1985 Apr; 27(2):100-5. PubMed ID: 3992882
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.
Lamarre-Cliche M; Souich Pd; Champlain Jd; Larochelle P
Clin Ther; 2008 Sep; 30(9):1629-38. PubMed ID: 18840368
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effect of almotriptan in treated hypertensive patients.
Fleishaker JC; McEnroe JD; Azie NE; Francom SF; Carel BJ
Clin Pharmacol Ther; 2002 Mar; 71(3):169-75. PubMed ID: 11907491
[TBL] [Abstract][Full Text] [Related]
28. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
29. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects.
Démolis JL; Kubitza D; Tennezé L; Funck-Brentano C
Clin Pharmacol Ther; 2000 Dec; 68(6):658-66. PubMed ID: 11180026
[TBL] [Abstract][Full Text] [Related]
30. Lack of effect of reboxetine on cardiac repolarization.
Fleishaker JC; Francom SF; Herman BD; Knuth DW; Azie NE
Clin Pharmacol Ther; 2001 Sep; 70(3):261-9. PubMed ID: 11557914
[TBL] [Abstract][Full Text] [Related]
31. QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients.
LLerena A; Berecz R; de la Rubia A; Dorado P
J Psychopharmacol; 2002 Dec; 16(4):361-4. PubMed ID: 12503836
[TBL] [Abstract][Full Text] [Related]
32. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
33. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
34. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
[TBL] [Abstract][Full Text] [Related]
35. Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.
Kim BH; Yi S; Kim J; Lim KS; Kim KP; Lee B; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Jun; 31(6):1234-43. PubMed ID: 19695390
[TBL] [Abstract][Full Text] [Related]
36. Greater quinidine-induced QTc interval prolongation in women.
Benton RE; Sale M; Flockhart DA; Woosley RL
Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
[TBL] [Abstract][Full Text] [Related]
37. Single dose pharmacodynamics of thioridazine and remoxipride in healthy younger and older volunteers.
Swift CG; Lee DR; Maskrey VL; Yisak W; Jackson SH; Tiplady B
J Psychopharmacol; 1999; 13(2):159-65. PubMed ID: 10475722
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting drug concentrations and QT interval during thioridazine therapy.
Thanacoody RH; Daly AK; Reilly JG; Ferrier IN; Thomas SH
Clin Pharmacol Ther; 2007 Nov; 82(5):555-65. PubMed ID: 17460606
[TBL] [Abstract][Full Text] [Related]
39. Electrocardiographic changes and serum concentrations in thioridazine-treated patients.
Axelsson R; Aspenstrom G
J Clin Psychiatry; 1982 Aug; 43(8):332-5. PubMed ID: 7096274
[TBL] [Abstract][Full Text] [Related]
40. Thioridazine dose-related effects on biomechanical force platform measures of sway in young and old men.
Liu YJ; Stagni G; Walden JG; Shepherd AM; Lichtenstein MJ
J Am Geriatr Soc; 1998 Apr; 46(4):431-7. PubMed ID: 9560064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
